A Single-center, Single-dose, Randomized, Open-label, Single-period, Parallel Bioequivalence Study of HRS9531 Injection Solution in Multi-dose Pens and Single-dose Pens in Overweight/Obese Subjects
Latest Information Update: 04 Feb 2025
Price :
$35 *
At a glance
- Drugs HRS 9531 (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- Sponsors Fujian Shengdi Pharmaceutical
- 04 Feb 2025 New trial record